Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19-Reference-Cited by-同舟云学术

Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19

Published:2020-08 Issue: Volume:109 Page:154282
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Dalamaga Maria,Karampela Irene,Mantzoros Christos S.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference43 articles.

1. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area;Richardson;JAMA,2020

2. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study;Yang;Lancet Respir Med,2020

3. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China;Wu;JAMA Intern Med,132020

4. The pathogenesis and treatment of the `cytokine Storm’ in COVID-19;Ye;J Infect,2020

5. Immunomodulation in COVID-19;Ingraham;Lancet Respir Med,2020

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrin α ₅ β ₁ contributes to cell fusion and inflammation mediated by SARS-CoV-2 spike via RGD-independent interaction;Proceedings of the National Academy of Sciences;2023-12-07

2. Sonochemical synthesis, docking studies and in vitro evaluation of imidazo-1,3-oxazinone derivatives as potential inhibitors of TNF-α;Journal of Molecular Structure;2023-11

3. Ultrasound assisted synthesis of 4-(1H-indol-3-yl)thieno[2,3-d]pyrimidine derivatives via AcOH mediated C C bond forming reaction;Tetrahedron Letters;2023-11

4. Synthesis of 2,3-dihydroquinazolin-4(1H)-one derivatives as potential inhibitors of TNF-α;Journal of Molecular Structure;2023-09

5. Modulation of Human Dendritic Cell Functions by Phosphodiesterase-4 Inhibitors: Potential Relevance for the Treatment of Respiratory Diseases;Pharmaceutics;2023-08-31